Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
NRX Pharmaceuticals, Inc. - Common Stock
(NQ:
NRXP
)
2.220
+0.090 (+4.23%)
Streaming Delayed Price
Updated: 2:27 PM EST, Nov 24, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about NRX Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Earnings Scheduled For November 17, 2025
↗
November 17, 2025
Via
Benzinga
Earnings Outlook For NRX Pharmaceuticals
↗
November 14, 2025
Via
Benzinga
Alphabet To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday
↗
October 30, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
August 22, 2025
Via
Benzinga
Insights Ahead: NRX Pharmaceuticals's Quarterly Earnings
↗
August 13, 2025
Via
Benzinga
HOPE Therapeutics Secures Financing For Ketamine Clinic Expansion
↗
August 26, 2024
HOPE Therapeutics, Inc., a subsidiary of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP),
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
August 19, 2025
Via
Benzinga
Why Small-Cap Biotech NRx Pharmaceuticals Is Drawing Heavy Retail Buzz
↗
August 12, 2025
NRx said the FDA’s fast-track status makes NRX-100 eligible for the Commissioner’s National Priority Voucher program and the FDA’s Accelerated Approval pathway, and the company has already applied for...
Via
Stocktwits
Uncovering Potential: NRX Pharmaceuticals's Earnings Preview
↗
May 14, 2025
Via
Benzinga
Stocktwits Spotlight: NRx, CVS, ReShape Lead Weekly Jump In Health Care Stock Chatter
↗
May 04, 2025
Favorable regulatory moves for a new drug application, blowout earnings and promising preclinical data triggered a flurry of discussions on Stocktwits for these tickers for the week ended April 11,...
Via
Stocktwits
Topics
Intellectual Property
Law Enforcement
Lawsuit
Amazon.com To $253? Here Are 10 Top Analyst Forecasts For Tuesday
↗
April 29, 2025
Via
Benzinga
Earnings Scheduled For May 15, 2025
↗
May 15, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
March 17, 2025
Via
Benzinga
Earnings Scheduled For March 17, 2025
↗
March 17, 2025
Via
Benzinga
Small-Cap NRx Pharma’s Stock Draws Heavy Retail Buzz After Securing $27M Funding
↗
January 29, 2025
Chairman Jonathan Javitt said the resources committed are expected to bring NRx to the $100 million revenue threshold.
Via
Stocktwits
What's Going On With NRX Pharmaceuticals Stock Tuesday?
↗
January 28, 2025
NRX Pharmaceuticals shares are moving higher on Tuesday after it invested $27 million in its subsidiary HOPE Therapeutics.
Via
Benzinga
What's Going On With NRX Pharmaceuticals Stock Thursday?
↗
January 02, 2025
NRX shares are trading higher on Thursday after the company announced a joint acquisition initiative with Hope Therapeutics to buy Kadima Neuropsychiatry Institute.
Via
Benzinga
Why MicroStrategy Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket
↗
January 02, 2025
Shares of MicroStrategy Incorporated (NASDAQ:MSTR) rose sharply in today's pre-market trading.
Via
Benzinga
NRXP Stock Earnings: NRX Pharmaceuticals Misses EPS for Q2 2024
↗
August 14, 2024
NRXP stock results show that NRX Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
May 16, 2024
Via
Benzinga
NRXP Stock Earnings: NRX Pharmaceuticals Misses EPS for Q1 2024
↗
May 14, 2024
NRXP stock results show that NRX Pharmaceuticals missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
↗
May 06, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
May 01, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
April 30, 2024
Via
Benzinga
Gold Down Over 2%; 3M Profit Beats Expectations
↗
April 30, 2024
Via
Benzinga
Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
April 30, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
April 30, 2024
Via
Benzinga
Why Is NRx Pharmaceuticals Stock Falling After Data From Suicidal Bipolar Depression Study
↗
April 30, 2024
NRX Pharmaceuticals announces Phase 2b/3 trial findings of NRX-101 vs. Lurasidone for Suicidal Bipolar Depression.
Via
Benzinga
Nasdaq Down 0.5%; Lithium Americas Shares Slide
↗
April 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
April 18, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today